AbstractObjectiveTo evaluate the emerging role of robotic‐assisted radical cystectomy (RARC) in the management of bladder cancer.MethodsReview of the published literature on robotic‐assisted radical cystectomy, including data from our cystectomy series of 30 patients.ResultsNearly 150 procedures have been performed worldwide. The benefits of robotic‐assisted operations are similar to those of laparoscopically‐performed procedures. RARC appears to be technically safe, oncologically and functionally equivalent to open (ORC) and laparoscopic radical cystectomy (LRC). However, RARC offers superior ergonomics and better vision. These benefits come at extra initial capital expenditure and subsequent higher maintenance costs.ConclusionWith the rapid spread of robotics, it is likely that RARC will become the standard of care in units with access to the technology. Copyright © 2008 John Wiley & Sons, Ltd.